TCT-627 Novel Sirolimus Eluting Stent With Fusion Coating Technology to Address the “Diabetes Issue”: 2-Year Result of the en-ABL e-Registry

Patients with diabetes mellitus (DM) have poorer outcomes after percutaneous coronary intervention than those without diabetes. We evaluate the 2-year safety and efficacy profile of the Abluminus DES+ in patients with diabetes within the population enrolled in the large multicenter en-ABL e-registry